IPO registrations (S-1, F-1) · Registrants
CORNERSTONE THERAPEUTICS INC
- SEC CIK
- 1145404 · filings on EDGAR ↗
- Name on the registration
- CRITICAL THERAPEUTICS INC
- Former names
- CRITICAL THERAPEUTICS INC (2002–2008)
- Registration
- Form S-1, first filed 2004-03-19, last 2004-05-26; 1 initial registration, 5 amendments
- Outcome
- Final prospectus filed 2004-05-27
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1255 CRESCENT GREEN DRIVE, SUITE 250, Cary, NC 27518
- EIN
- 04-3523569
- EDGAR entity type
- operating
- Insiders and CEO pay
- CORNERSTONE THERAPEUTICS INC on the corporate pages
Offering terms
- Proposed price range
- $7.00–$9.00 per share (S-1/A filed 2004-05-26)
- Final price
- $7.00 per share, within the range (424B1 filed 2004-05-27, an initial public offering)
- Shares sold
- 6,000,000
- Gross proceeds
- $42,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CRTX
- Lead underwriters
- Cowen (2,592,000 shares)
- Syndicate
- CIBC World Markets (1,134,000); Piper Sandler (1,134,000); Leerink Partners (540,000); Adams Harkness (100,000); Baird (100,000); Fortis Securities Inc (100,000); Needham & Company (100,000); Sanders Morris Harris Inc (100,000); Thomas Weisel Partners (100,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: CORNERSTONE THERAPEUTICS INC EXACT (CIK (EXACT))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2004-03-19 | S-1 | S-1 (registration) | CRITICAL THERAPEUTICS INC | 0000950135-04-001416 ↗ |
| 2004-04-22 | S-1/A | S-1/A (amendment) | CRITICAL THERAPEUTICS INC | 0000950135-04-001972 ↗ |
| 2004-05-10 | S-1/A | S-1/A (amendment) | CRITICAL THERAPEUTICS INC | 0000950135-04-002525 ↗ |
| 2004-05-21 | S-1/A | S-1/A (amendment) | CRITICAL THERAPEUTICS INC | 0000950135-04-002764 ↗ |
| 2004-05-25 | S-1/A | S-1/A (amendment) | CRITICAL THERAPEUTICS INC | 0000950135-04-002790 ↗ |
| 2004-05-26 | S-1/A | S-1/A (amendment) | CRITICAL THERAPEUTICS INC | 0000950135-04-002807 ↗ |
| 2004-05-27 | 424B1 | 424B1 (final prospectus) | CRITICAL THERAPEUTICS INC | 0000950135-04-002832 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2004-05-26 | S-1/A | registration statement | $7.00–$9.00 | 6,000,000 | - | Nasdaq CRTX | 6 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, underwriting table 2, cover names 4 | document ↗ | |
| 2004-05-27 | 424B1 | final prospectus | $7.00 | 6,000,000 | $42,000,000 | Nasdaq CRTX | 10 | primary document; price sentence, shares headline, proceeds table, underwriting table 10, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Finnegan Frederick | Officer | SVP of Sales and Marketing | 1 | 2006 | |
| Newman Walter | Officer | CSO/SVP Research & Development; CSO/SVP Research & Discovery | 2 | 2006 | |
| Phillips Trevor | Officer | COO and SVP of Operations; Former President & CEO | 11 | 2006–2008 | |
| RUBIN PAUL D | Director,Officer | President and CEO | 4 | 2006 | |
| THOMAS FRANK E | Director,Officer; Officer | CFO, SVP Finance and Treasurer; President; President & CEO | 10 | 2006–2007 | |
| Townsend Scott B | Officer | GENERAL COUNSEL and EVP LEGAL; GENERAL COUNSEL and SVP LEGAL; GENERAL COUNSEL AND VP LEGAL; VP OF LEGAL AFFAIRS AND SEC. | 10 | 2006–2009 | |
| Warren Howland Shaw | Director | 8 | 2006 | ||
| DUGAN RICHARD W | Director; DirectorOther | 2 | 2006–2007 | ||
| George Jean | Director | 2 | 2006–2007 | ||
| WALSH CHRISTOPHER T PHD | Director | 3 | 2006–2007 | ||
| Zeiger Robert H | Director; Director,Officer | EXECUTIVE CHAIRMAN | 3 | 2006–2007 | |
| GALAKATOS NICHOLAS | Director; Director,TenPercentOwner | 3 | 2006–2007 | ||
| TANANBAUM JAMES B | Director | 6 | 2006–2007 | ||
| Hilt Dana Charles | Officer | SVP of Clinical Develop. & CMO | 3 | 2006 | |
| Young Jeffrey E | Officer | FORMER VP FINANCE & CAO; VP FINANCE, CAO AND TREASURER | 8 | 2006–2008 | |
| Zwerling M Cory | Director | 4 | 2006–2007 | ||
| EVNIN LUKE | Other | 2 | 2007 | ||
| GADICKE ANSBERT | Other | 2 | 2007 | ||
| MPM ASSET MANAGEMENT II LLC | Other | 1 | 2007 | ||
| MPM ASSET MANAGEMENT II LP | Other | 1 | 2007 | ||
| MPM ASSET MANAGEMENT INVESTORS 2001 LLC | Other | 1 | 2007 | ||
| MPM BIOVENTURES II GMBH & CO PARALLEL BETEILIGUNGS KG | Other | 1 | 2007 | ||
| MPM BIOVENTURES II LP | Other | 1 | 2007 | ||
| MPM BIOVENTURES II QP LP | Other | 1 | 2007 | ||
| STEINMETZ MICHAEL | Other | 2 | 2007 | ||
| WHEELER KURT | Other | 2 | 2007 | ||
| Kelly Thomas Patrick | Officer | CFO & SVP Finance & Corp. Dev, | 5 | 2007–2008 | |
| Baldwin Chenyqua Michele | Officer | Vice President Finance | 2 | 2008 | |
| CODEANNE CHRISTOPHER GEORGE | Director | 8 | 2008–2014 | ||
| Collard Craig A | Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer; President and CEO | 11 | 2008–2014 | |
| Dickson Brian | Officer | Chief Medical Officer | 6 | 2008–2009 | |
| Enright Michael David | Director | 8 | 2008–2014 | ||
| Esgro George Arthur | Officer | Vice President Sales | 2 | 2008 | |
| Heffernan Michael Thomas | Director | 9 | 2008–2014 | ||
| Lutz Steven Michael | Officer | Executive Vice President | 7 | 2008–2011 | |
| MCEWAN ALASTAIR STUART | Director; Officer | CFO and Treasurer | 12 | 2008–2014 | |
| Price David | Officer | Chief Financial Officer | 6 | 2008–2010 | |
| Carolina Pharmaceuticals Holdings, Ltd. | TenPercentOwner | 1 | 2008 | ||
| Carolina Pharmaceuticals Ltd. | TenPercentOwner | 1 | 2008 | ||
| Cornerstone Biopharma Holdings, Ltd. | TenPercentOwner | 2 | 2008–2009 | ||
| Franklin Joshua B | Officer | VP, Sales and Marketing; VP, Strategy & Bus. Dev. | 13 | 2008–2014 | |
| Chiesi Alessandro | Director | 4 | 2009–2012 | ||
| Chiesi Farmaceutici SpA | TenPercentOwner | 11 | 2009–2014 | ||
| Chiesi Maria Paola | Director | 1 | 2009 | ||
| Failla Anton Giorgio | Director | 6 | 2009–2014 | ||
| Stephan Robert | Director | 6 | 2009–2014 | ||
| Powell Andrew Kenneth William | Officer | EVP, General Counsel | 11 | 2009–2013 | |
| Roberts Alan | Officer | VP, Scientific Affairs | 9 | 2009–2014 | |
| Duarte Ira | Officer | Principal Accounting Officer | 5 | 2010–2014 | |
| Vecchia Marco | Director | 6 | 2010–2014 | ||
| Morgus Vincent T. | Officer | EVP, Finance and CFO | 6 | 2011–2012 | |
| McBean Kenneth | Officer | President | 7 | 2011–2014 | |
| Harper James A | Director | 6 | 2011–2014 | ||
| Shawver Laura | Director | 4 | 2012–2014 | ||
| Chiesi U.S. Corp | TenPercentOwner | 1 | 2013 | ||
| Maetzel Andreas | Officer | VP, Clinical and Regulatory | 3 | 2013–2014 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Patent assignee | Cornerstone Therapeutics, Inc. | NC | Patents (USPTO) | name and state |
| SEC filer | CORNERSTONE THERAPEUTICS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | CORNERSTONE THERAPEUTICS INC. | NC | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NC first:
- SALIX PHARMACEUTICALS LTD NC
- TRIANGLE PHARMACEUTICALS INC NC
- INSPIRE PHARMACEUTICALS INC NC
- POZEN INC /NC NC
- ARGOS THERAPEUTICS INC NC
- CHIMERIX INC NC
- ENDEAVOR PHARMACEUTICALS INC NC
- Talecris Biotherapeutics Holdings Corp. NC
- Biolex Therapeutics, Inc. NC
- CURAXIS PHARMACEUTICAL Corp NC
In other datasets, the same topic (Health) in NC:
- Nonprofit: 24 FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health